loader

World Tenders & Procurement Opportunities

Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Isorbiddinitrat, ATC-Code: C01DA08 für die Zeit vom 1.5.2021 bis zum 30.4.2023

World Biggest Tenders Source

This tender with title Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Isorbiddinitrat, ATC-Code: C01DA08 für die Zeit vom 1.5.2021 bis zum 30.4.2023 -- Pharmaceutical products has been published on Bidding Source portal dated 31 Mar 2021 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Pharmaceutical products

General Information

Abschluss eines nicht-exkl. Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Isorbiddinitrat, ATC-Code: C01DA08 für die Zeit vom 1.5.2021 bis zum 30.4.2023
Pharmaceutical products
Invitation for Bids
2021/S 062-156719
Germany
Germany-Leverkusen
31 Mar 2021
5 Mar 2023
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient brimonidine in the dosage form EDP - Germany - 323028-2024 Germany Pharmaceutical products – conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient pegfilgrastim (ATC code according to WHO: L03AA13) - Germany - 322913-2024 Germany Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient filgrastim (ATC code according to WHO: L03AA02) - Germany - 323326-2024 Germany Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient somatropin (ATC code according to WHO: H01AC01) - Germany - 323563-2024 Germany Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V by means of a so-called open house model for medicinal products with the trade name Grazax(R) (ATC code according to WHO: V01AA02) - Germany - 324150-2024 Germany Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient acetylcysteine ​​as an OTC medicinal product - Germany - 319132-2024 Germany Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V by means of a so-called open house model for medicinal products with the trade name Acarizax(R) (ATC code according to WHO: V01AA03) - Germany - 323194-2024 Germany Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient acarbose - not in standard size 2 - Germany - 319589-2024 Germany Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient ebastine in the strength 20 mg and the dosage form SMT - Germany - 322099-2024 Germany Pharmaceutical products – Conclusion not excluding AM discount agreement according to Section 130a Paragraph 8 SGB V by means of an OH model for the WS Epoetin alfa (genetically engineered human erythropoietin - restriction to packs with doses up to 10,000 IU) - Germany - 322308-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans